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The term “risk factor” dates beck more than four decades to 
the early days of the Framingham experiment. It has become 
one of cardiology’s most widely used phrases. For coronary 
artery disease, it is axiomatic that cholesterol, hypertension 
and cigarette smoking, among others, are risk factors. So 
ingreined is this concept that coronary disease without risk 
factors is a clinical anomaly to be pondered. 
The idea of risk in American society is so pervasive that 
in 1990. Dsedalus, the quarterly journal of the American 
Academy of Arts and Sciences. devoted an entire issue to 
risk. Once used for uncertain ventures undertaken with the 
hope of substantial gain. today the term “risk” is Qerceived 
in the United State?, perhaps more than elsewhere, as an 
unnecessary hazard of contemporary life against which the 
individual needs 10 be protected. 
As physicians and cardiologists, we expend much of oar 
e;?otianal and intellectual energy on the concept of risk. 
Many controversies in cardiology arise from contrasting 
views of risk. both to individuals and to populations. Among 
such controversies, for example, are the questions of uni- 
versal salt restriction to prevent high blood pressure and 
worn cholesterol reduction for coronary disease. 
Physicians, trained to treat the sick, now face the dilem. 
mas of how fw to go in recommending significant dietary and 
life-style changes and when to prescribe expensive and 
potent medicines for obstensibly well persons who may be at 
risk. In his recent book, “The Strategy of F’reventivz Med- 
icine,” Rofessor Geoffrey Rose (I), recently retired from 
the Chair of Epidemiology at the London School of Hy&ne 
and Tropical Medicine, has some incisive thoughts for US on 
the issues of risk and prevention. 
He opens with a quotation from Virchor: “The history of 
epidemics is the history of disturbances in human culture.” 
From this flows the idea that ultimatelv to control direav 
one must control societal (risk) factors that give rise to it. 
The ewnce of Rose’s message is that to the epidemiologist 
thepopularion is the patient aad statistics are the measure of 
sacccss. Rose coatmsts this -witit the vantage point of the 
physician who treats a person already ill or advises aa 
individual apparently wet1 but thought to bc at high risk. 
nkgh risk versus pqmlathm straw of Qmtattm. 
There are two approaches to the contmi of disease. One is 
the high risk srrmgy of prevention. The other is the popu- 
lation stmtqy of prevenrion. The high risk strategy seeks 
out and treats the individual-for example. the patient with 
hypertensicn or hyparlipidemia. The intervention is appm 
oriate tothe condition. This aomoach avoids interferinn with 
~&?&as not at material risk. ii is consistent. Rose so&s, 
with the “ethos and organization of medical care.” _- 
3n the other hand. to intervene with life-style chanae or 
Qrophylwtic medication on a mass basis in p&sons a&w- 
cntly well, who have minimal or no risk factors, is to use the 
popularion srraregy of prevention. The objective is to modify 
a risk factor, however slight, in the hope of preventing future 
disease in the population at large. In this circumstance. the 
distinction between normalcy and disease, bx tween preven- 
tion and treatment, becomes blurred. 
The high risk strategy has specific advaatages. It is cost 
affective in use of resoarees. There is likely to be a high 
benefit to risk ratio. 
Rose does w&eat some weaknesses in I+ hi risk 
shaegy. Tbaugh it may help those at high risk, it ignores 
large numbers of people at relatively low risk. Yet, it is the 
latter group that generates more cases than occur in the 
relatively small high risk category. For example. less than 
if% of fatal heart allacks may occur in individuals with a 
high cholesterol level, while a much larger number of attacks 
will occur in persons who don’t meet the criteria for high 
risk. In other words, the high risk strategy can prevent only 
a relatively small minority of potential heart attacks. 
:he community. This creale~ ala impasse. A strategy that 
might be effective for a selected group of high risk individ- 
ualr may be inappropriate for society. It IS analogous to 
emergency famine relief. which will help a targeted few but 
will not solve the alobal nroblem of famine. 
lfthe high risk group is defined too bmadly. it will include 
many who are unlikely everto have apmblemand whodon’t 
need intervention. If it is defined too narrowly. it wi!l 
contribute little toward reducine the incidence of disease in 
pmach to an individual uatient, is based on the u&ability 
that a behavior or an ~&ore will do more harm&t gwd. 
But there will alwavs be uncertainty. The mediais ztfaoltfor 
exagaeeiating certainty and for h&lining simple, supe&iaI 
and clewcut stetentents. Naturally, the public prefers the 
comfort of certainty tothe discomfort ofbalance and candor. 
Epidemiologic &dies are designed to show the impact of 
an intervention or achange in behavior on populations. They 
decision making-is about. E&tbling or eliminating a trivial 
are cot mended to be the basis for clinical decision making 
in ibs iadividuai patient. it is a f?&cy tc eqrnte epidemio 
risk wtil have trivial impaft. Rose asks how low a t-irk must 
logic studies ivith carefolly controlled scientific clinical hi- 
ah. In his population strategy of prevention, Rose himself 
be before it can be considered uegliglbIe. but he gives no 
warns that wine euidemioloaic data is not what clinical 
answer. 
The concent of nealialble benefit is the comllaw of 
Rose clearly fators the poptlntion strategy of prevention. 
Prevention begins with the recognition that the occurrence 
of contmon diseases and the prevalence of high risk reflect 
the behavior and circumstances of society. It follows from 
this philosophy that a modest fall in the average chnlesterol 
level of the entire population will be more effective in 
reducing fatal heart attacks than will the eradication of all 
so-called hieh cholesterol levels. which occur in relativelv 
few p&e.- 
The prevention paradox. Attractive as this strategy of 
urevention tnav be, its Achilles’ heel is “the prevention 
Paradox.” Tbu~. a person at low risk may not be-helped by 
reducing salt. fal ora modest alcohol intake, even though the 
entire population might benefit a great deal in terms of 
statistical reduction in disease prevalence. From the point of 
view of the epidemiologist, where there is mass oap_oore to 
risk, even at low level, there is need for mass measore~ of 
control. This means reducing the risk to large numben of 
people who will not benefit from the change. Again. the 
prevention paradox. 
Rose has some candid views on the scientific basis for 
change in health policy. He thinks that public policy makers, 
medical scientists and the media need to understand that we 
can never be certain of anything. The results of research 
studies are expected to be positive or negative. indicating 
that a particular exposure does or does not caose a disease or 
that a particular intervention is or is not e&ctive. Thts is 
rarely the case. Prevention policy. like a physician’s ap 
_- 
negligible risk. Even a statistically significant intervention 
may hwe negligible bonelit for the individual. Rose con- 
cedes that “the healthcare prize may he the diierence 
between life and deal:,, bttt ifthe statistical chance that it will 
alfect a parttcular individual is too small or remote. people 
may not want to bother.” On!y if society chooses to bother 
can prevention really be effective. Rose adds that “grateful 
patients are few in preventive medicine where success is 
marked by a nonevent.” 
Rose has defined the prevention paradox as it applies to 
tSe population prevention strategy. Perhaps this concept 
should be expanded to include the high risk strategy. For 
even in lhe high risk approach, many must be treated for a 
few to benefit. Not everyone with high blood pressure will 
experience an unfavorable event, nor wil! everyone with a 
high iholesteml level develop coronary disease. What the 
c&o should be of those Mated or subjected to l&style 
change to those actually helped remains an unsolved di- 
lemma for doctor, patient and society. Until the pmgnostic 
implications of lhe various risk factors are refined, this 
dilemma will remain. So will uncerlainly for the individual in 
the preven ion paradox. 
